| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
33 |
S8 |
p. x
|
artikel
|
| 2 |
CRUK
|
|
|
|
33 |
S8 |
p. viii
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
33 |
S8 |
p. i
|
artikel
|
| 4 |
ESMO
|
|
|
|
33 |
S8 |
p. vi
|
artikel
|
| 5 |
1MO Air pollution-induced non-small cell lung cancer: Towards molecular cancer prevention
|
Lim, E.
|
|
|
33 |
S8 |
p. S1383
|
artikel
|
| 6 |
3MO Genomic evolution of non-small cell lung cancer during the establishment and propagation of patient-derived xenograft models
|
Hynds, R.
|
|
|
33 |
S8 |
p. S1384
|
artikel
|
| 7 |
5MO Hypomethylation of circulating retrotransposons: Towards a non-invasive pan-cancer diagnosis
|
Proudhon, C.
|
|
|
33 |
S8 |
p. S1385
|
artikel
|
| 8 |
Molecular Analysis for Precision Oncology Congress 2022 Officers
|
|
|
|
33 |
S8 |
p. ix
|
artikel
|
| 9 |
7MO Measuring proliferation rates of distinct tumour clones using single-cell DNA sequencing
|
Lucas, O.J.
|
|
|
33 |
S8 |
p. S1385-S1386
|
artikel
|
| 10 |
4MO Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer
|
Murtha, A.J.
|
|
|
33 |
S8 |
p. S1384
|
artikel
|
| 11 |
6MO Pan-cancer characterization of receptor tyrosine kinases alterations to sort targetable drivers from passengers
|
Vanacker, H.
|
|
|
33 |
S8 |
p. S1385
|
artikel
|
| 12 |
2MO Tracking immunoediting from early to late-stage lung cancer
|
Hessey, S.
|
|
|
33 |
S8 |
p. S1383-S1384
|
artikel
|
| 13 |
52P Affordable cancer research for under-resourced settings to implement precision medicine: The tale of the Moroccan OVANORDEST-1 study
|
El Bairi, K.
|
|
|
33 |
S8 |
p. S1399
|
artikel
|
| 14 |
8P A gradient boosting decision tree (GBDT) approach to identify potential therapeutic targets
|
Kifer, I.K.
|
|
|
33 |
S8 |
p. S1386
|
artikel
|
| 15 |
60P ALKBH1 alterations predict poor prognosis in oral squamous cell carcinoma
|
Arumugam, P.
|
|
|
33 |
S8 |
p. S1401-S1402
|
artikel
|
| 16 |
21P Analytical performance of FusionPlex Dx
|
Haddad, V.
|
|
|
33 |
S8 |
p. S1390
|
artikel
|
| 17 |
133P ARID1A-mutated cancers: New prospectives for treatment of a subgroup of gynecological cancer
|
Falcone, R.
|
|
|
33 |
S8 |
p. S1425
|
artikel
|
| 18 |
123P Associations between N-cadherin (N-cad) as an epithelial-mesenchymal transition (EMT) marker and androgen (AR) and estrogen receptors (ER) expression in prostate cancer (PCa)
|
Puchinskaya, M.
|
|
|
33 |
S8 |
p. S1421
|
artikel
|
| 19 |
121P ATM germline mutations in lethal prostate cancer
|
Grochot, R.M.
|
|
|
33 |
S8 |
p. S1420-S1421
|
artikel
|
| 20 |
84P Autologous ECM-composed scaffolds and zebrafish PDXs for individualized theranostics in rare neuroendocrine neoplasms
|
Calabrese, C.
|
|
|
33 |
S8 |
p. S1409
|
artikel
|
| 21 |
115P Bicentric real-life analysis of the molecular portrait of patients with metastatic biliary tract cancer
|
Schmalfuss, T.K.
|
|
|
33 |
S8 |
p. S1419
|
artikel
|
| 22 |
61P Biomarkers EGFR, p53, IDH1 and MDM2 as prognostic indicators for overall survival of glioblastoma patients
|
Ali, S.M.A.
|
|
|
33 |
S8 |
p. S1402
|
artikel
|
| 23 |
75P Biosynthesis and characterization of selenium nanoparticles using marine algae Sargassum wightii: Understanding its anticancer activity through ROS-mediated p53 and Akt signaling pathways in A549 cells
|
Loganathan, C.
|
|
|
33 |
S8 |
p. S1406
|
artikel
|
| 24 |
22P Breast cancer pharmacogenomics: Targeted therapies in Asian women with breast cancer using drug-metabolizing enzymes
|
Singh Yadav, S.
|
|
|
33 |
S8 |
p. S1390
|
artikel
|
| 25 |
94P CD44v6: A potential therapeutic target for liver carcinoma
|
Srikanth, A.
|
|
|
33 |
S8 |
p. S1412
|
artikel
|
| 26 |
109P Characteristics of clonal hematopoiesis-related mutations identified in liquid biopsies from patients with metastatic solid tumors
|
Vasseur, D.
|
|
|
33 |
S8 |
p. S1416-S1417
|
artikel
|
| 27 |
74P Characterizing the beta-catenin interactome using inhibitor screens and novel interaction proteomics techniques
|
John, S.
|
|
|
33 |
S8 |
p. S1406
|
artikel
|
| 28 |
131P Clinical and molecular analysis of advanced salivary gland tumors at a tertiary care cancer center in a low-middle-income country
|
Sansar, B.
|
|
|
33 |
S8 |
p. S1424
|
artikel
|
| 29 |
39P Clinical relevance of alterations in cancer (CRAC): A DB for selecting biomarkers for molecularly matched therapy in cancer patients
|
Lebedeva, A.
|
|
|
33 |
S8 |
p. S1396
|
artikel
|
| 30 |
27P Clinical relevance of NGS analysis in endometrial cancer (EC) management
|
Giudice, E.
|
|
|
33 |
S8 |
p. S1392
|
artikel
|
| 31 |
110P Clinical validation of a 50-gene hotspot NGS panel in Asian patients with solid tumors
|
Lim, D.
|
|
|
33 |
S8 |
p. S1417
|
artikel
|
| 32 |
112P Clinicopathological characterization of MTAP-altered metastatic gastrointestinal tumors
|
Mauri, G.
|
|
|
33 |
S8 |
p. S1418
|
artikel
|
| 33 |
126P Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer
|
Huang, C-Y.
|
|
|
33 |
S8 |
p. S1422
|
artikel
|
| 34 |
137P Combining protein and mRNA spatial profiles to identify distinct cell population in metaplastic breast cancer
|
Kuasne, H.
|
|
|
33 |
S8 |
p. S1426
|
artikel
|
| 35 |
55P Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)
|
Robinson, I.
|
|
|
33 |
S8 |
p. S1400
|
artikel
|
| 36 |
73P Comparison of FDA-approved and laboratory developed next generation sequencing panels in patients with advanced cancers
|
Kuznetsova, O.
|
|
|
33 |
S8 |
p. S1405-S1406
|
artikel
|
| 37 |
135P Comparison of serum level WT1 gene and its expression in ovarian cancer
|
Dubey, H.
|
|
|
33 |
S8 |
p. S1425-S1426
|
artikel
|
| 38 |
119P Comprehensive DNA analysis of primary penile carcinoma by target NGS
|
Hojný, J.
|
|
|
33 |
S8 |
p. S1420
|
artikel
|
| 39 |
108P Comprehensive genomic analysis: A hype or hope?
|
Srinivasalu, V.K.
|
|
|
33 |
S8 |
p. S1416
|
artikel
|
| 40 |
141P Comprehensive genomic profiling-based precision oncology in the management of rare paediatric soft tissue sarcomas
|
Cervi, C.
|
|
|
33 |
S8 |
p. S1427
|
artikel
|
| 41 |
139P Comprehensive genomic profiling reveals possible targeted treatment options and novel variants in pediatric primary central nervous system tumors
|
Bedics, G.
|
|
|
33 |
S8 |
p. S1427
|
artikel
|
| 42 |
35P Copy number variation detection from targeted amplicon-based high-throughput sequencing in clinical settings
|
Yakushina, V.
|
|
|
33 |
S8 |
p. S1394
|
artikel
|
| 43 |
66P DDB2 influences epithelial-to-mesenchymal transition and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma cells
|
Dardare, J.
|
|
|
33 |
S8 |
p. S1403
|
artikel
|
| 44 |
19P Deciphering the role of precision oncology in the treatment of biliary tract cancer in daily routine practice: Retrospective analysis from the cancer center Upper Austria
|
Doleschal, B.
|
|
|
33 |
S8 |
p. S1389-S1390
|
artikel
|
| 45 |
51P Deep dive in triple-negative breast cancer (TNBC) is a need in the era of precision medicine
|
Bakri, H.M.
|
|
|
33 |
S8 |
p. S1399
|
artikel
|
| 46 |
10P Detection of early-stage lung cancer using 5-hydroxymethylcytosine signatures in circulating cell-free DNA
|
Kang, X.
|
|
|
33 |
S8 |
p. S1387
|
artikel
|
| 47 |
142P Developing emerging AI technologies to empower precision medicine: Advanced queries, search and biomedical predictions leveraging disparate oncology unstructured data compendia
|
Sharma, V.
|
|
|
33 |
S8 |
p. S1428
|
artikel
|
| 48 |
97P Development of a cas9-expressing gastrointestinal stromal tumor cell line T1-1M-R
|
Skripova, V.
|
|
|
33 |
S8 |
p. S1413
|
artikel
|
| 49 |
144P Development of a 6-color multiplex crystal digital PCR assay for the simultaneous detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients
|
Corné, J.
|
|
|
33 |
S8 |
p. S1428
|
artikel
|
| 50 |
104P Development of a new generation of imatinib using structural biology techniques at ambient temperature
|
Usta, G.
|
|
|
33 |
S8 |
p. S1415
|
artikel
|
| 51 |
90P Dextran-based polymers can be used as first choice to generate tumor spheroids in vitro
|
Enciu, A-M.
|
|
|
33 |
S8 |
p. S1411
|
artikel
|
| 52 |
58P Diabetes mellitus and BMI as predictors of overall survival in oral squamous cell carcinoma patients
|
Mirza, Y.
|
|
|
33 |
S8 |
p. S1401
|
artikel
|
| 53 |
25P Differential response to platinum agents of patients carrying the germline BRCA1 c.211 A>G pathogenic variant
|
Gomez-Randulfe Rodriguez, M.I.
|
|
|
33 |
S8 |
p. S1391
|
artikel
|
| 54 |
138P Dissecting intra-tumoral heterogeneity in localized HR+/Her2− breast cancer using single cell DNA sequencing
|
Cerbone, L.
|
|
|
33 |
S8 |
p. S1426-S1427
|
artikel
|
| 55 |
80P Dual cell cycle arrest in KRAS mutant cell lines by co-inhibition of MAPK and Hippo-YAP1 pathways
|
Tammaccaro, S.L.
|
|
|
33 |
S8 |
p. S1408
|
artikel
|
| 56 |
20P Early detection and disease monitoring of hepatocellular carcinoma using circulating telomere DNA
|
Lian, S.
|
|
|
33 |
S8 |
p. S1390
|
artikel
|
| 57 |
81P Effect of disulfide bonds and N-glycosylation on the recognition of the NaPi2b transporter by monoclonal antibodies
|
Reshetnikova, D.
|
|
|
33 |
S8 |
p. S1408
|
artikel
|
| 58 |
54P EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome
|
Yang, H.
|
|
|
33 |
S8 |
p. S1400
|
artikel
|
| 59 |
130P Endothelin-1 promotes epithelial-mesenchymal transition in oral squamous cell carcinoma
|
Mukherjee, R.
|
|
|
33 |
S8 |
p. S1424
|
artikel
|
| 60 |
36P EP300 as an epigenetic target in p53 wild-type tumors treated with cisplatin
|
Robaszkiewicz, A.
|
|
|
33 |
S8 |
p. S1395
|
artikel
|
| 61 |
143P Evaluate the use of the residual liquid of Pap test for human papillomavirus (HPV) screening
|
Chu, E.S.
|
|
|
33 |
S8 |
p. S1428
|
artikel
|
| 62 |
145P Everolimus for the treatment of thymic epithelial tumors (TETs): A real-world experience
|
Florez Arango, J.D.
|
|
|
33 |
S8 |
p. S1429
|
artikel
|
| 63 |
116P Expression of Her2/Neu and Ki-67 proliferation index in gall bladder carcinomas: Clinicopathological significance
|
Singh, N.
|
|
|
33 |
S8 |
p. S1419
|
artikel
|
| 64 |
124P Feasibility of multidisciplinary translational CAPRICE project: Study protocol and workflow
|
Mendez Carrascosa, E.R.
|
|
|
33 |
S8 |
p. S1421-S1422
|
artikel
|
| 65 |
70P Genetic alterations and immune cell infiltration with potential impact on PD-(L)1 targeted treatment in various cancer entities: Biobank research project of the INFINITY registry
|
Vannier, C.
|
|
|
33 |
S8 |
p. S1404-S1405
|
artikel
|
| 66 |
132P Genomic profiling of primary and recurrent ovarian cancers: A retrospective single-center experience
|
Giudice, E.
|
|
|
33 |
S8 |
p. S1424-S1425
|
artikel
|
| 67 |
96P Goblet cell differentiation in colorectal cancer
|
Abdullayeva, G.
|
|
|
33 |
S8 |
p. S1412-S1413
|
artikel
|
| 68 |
37P Growth/differentiation factor-15 from biomarker to target in cancer
|
Stanciu, A.E.
|
|
|
33 |
S8 |
p. S1395
|
artikel
|
| 69 |
34P Gustave Roussy Match-R study: A descriptive analysis of the molecular target population
|
Florez Arango, J.D.
|
|
|
33 |
S8 |
p. S1394
|
artikel
|
| 70 |
87P High CD44 expression is associated with temozolomide resistance of glioblastoma cells
|
Strokotova, A.V.
|
|
|
33 |
S8 |
p. S1410
|
artikel
|
| 71 |
43P High intratumoral density of double-positive CD8/GRMZ lymphocytes, BRCAness and elevated TAP2 expression are predictive for improved breast cancer (BC) response to neoadjuvant chemotherapy (NACT)
|
Kuligina, E.S.
|
|
|
33 |
S8 |
p. S1397
|
artikel
|
| 72 |
67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC)
|
Cattrini, C.
|
|
|
33 |
S8 |
p. S1403-S1404
|
artikel
|
| 73 |
24P How far along is precision oncology with immune checkpoint inhibitors for triple-negative breast cancer? A meta analysis and position paper
|
Sarfraz, A.
|
|
|
33 |
S8 |
p. S1391
|
artikel
|
| 74 |
13P Hypermethylation of microRNA gene: Potential in the diagnosis of lung cancer
|
Pronina, I.
|
|
|
33 |
S8 |
p. S1388
|
artikel
|
| 75 |
114P Identification of cholangiocarcinoma-derived exosomal proteins biomarkers
|
Rana, R.
|
|
|
33 |
S8 |
p. S1418-S1419
|
artikel
|
| 76 |
79P Identification of disordered proteins as potential predictive biomarkers for cancer therapeutics based on network topology analysis
|
Schulc, K.
|
|
|
33 |
S8 |
p. S1407
|
artikel
|
| 77 |
49P Impact of cyclin D1/TβRII cells in the sensitivity to tamoxifen in hormone receptor-positive breast cancer
|
Babyshkina, N.
|
|
|
33 |
S8 |
p. S1398
|
artikel
|
| 78 |
17P Increased expression of POU5F1 in metastatic colorectal cancer is not caused by increased expression of OCT4A and OCT4B isoforms
|
Turyova, E.
|
|
|
33 |
S8 |
p. S1389
|
artikel
|
| 79 |
42P Independent prognostic value of flow cytometry (FCM) in myelodysplastic syndromes (MDS): Composition of a prognostic FCM-score for overall survival
|
Santaolalla, A.
|
|
|
33 |
S8 |
p. S1396
|
artikel
|
| 80 |
98P Induction of aggressive phenotype in a heterogeneous prostate cancer model
|
Kachalova, A.
|
|
|
33 |
S8 |
p. S1413
|
artikel
|
| 81 |
118P In-silico analysis of fibroblast growth factor receptors (FGFRs) as potential biomarkers for esophageal carcinoma
|
Srivastava, A.
|
|
|
33 |
S8 |
p. S1419-S1420
|
artikel
|
| 82 |
45P In silico transcriptomic mapping of Notch biological pathway in luminal breast cancer
|
Laimito, K.I. Rojas
|
|
|
33 |
S8 |
p. S1397
|
artikel
|
| 83 |
64P Integrative immune transcriptomic classification could improve patient selection for precision immunotherapy in advanced gastroesophageal adenocarcinoma
|
Cabeza Segura, M.
|
|
|
33 |
S8 |
p. S1402-S1403
|
artikel
|
| 84 |
16P KRAS and CTLA-4 expression profiling in circulating tumor cells in patients with colorectal cancers
|
Aktar, S.
|
|
|
33 |
S8 |
p. S1389
|
artikel
|
| 85 |
15P KRAS mutation in metastatic non-small cell lung carcinoma (NSCLC): The Indian subcontinent experience from a tertiary cancer center
|
Mukherjee, A.
|
|
|
33 |
S8 |
p. S1388
|
artikel
|
| 86 |
111P Leveraging in silico signatures to predict clinically actionable variants in oncogenes
|
Veselovsky, E.
|
|
|
33 |
S8 |
p. S1417-S1418
|
artikel
|
| 87 |
31P Liquid biopsies in clinical practice
|
Repana, D.
|
|
|
33 |
S8 |
p. S1393
|
artikel
|
| 88 |
72P Liquid biopsy biomarkers utility in radiation oncology
|
Cifuentes, G.A.
|
|
|
33 |
S8 |
p. S1405
|
artikel
|
| 89 |
11P Mapping the pattern and pace of tumour dissemination using longitudinal imaging and ctDNA in the TRACERx lung study
|
Liu, W.K.
|
|
|
33 |
S8 |
p. S1387
|
artikel
|
| 90 |
65P MicroRNA profiles associated with response to neoadjuvant chemotherapy in esophageal cancer patients
|
Sharma, R.
|
|
|
33 |
S8 |
p. S1403
|
artikel
|
| 91 |
93P Migrating cancer stem cell elimination by disrupting tumor-stroma crosstalk using CXCR4 targeting human endogenous peptides in PDAC
|
Tiwary, K.
|
|
|
33 |
S8 |
p. S1412
|
artikel
|
| 92 |
146P Miniature molecules and the Mammoth treatment changes in endometrial cancer
|
Verma, M.
|
|
|
33 |
S8 |
p. S1429
|
artikel
|
| 93 |
85P Mocetinostat (MGCD0103) or MG0103 is an isotype-selective histone deacetylase (HDAC) inhibitor induce apoptosis and suppress tumor in glioblastoma cell lines C6 and T98G
|
Khathayer, F.
|
|
|
33 |
S8 |
p. S1409
|
artikel
|
| 94 |
76P Modulation of mutant p53 activity using indazole derivatives
|
Davletshin, D.
|
|
|
33 |
S8 |
p. S1406-S1407
|
artikel
|
| 95 |
30P Molecular analysis of bone sarcomas by cytogenetic studies on fine needle aspiration samples
|
Mishra, A.N.
|
|
|
33 |
S8 |
p. S1393
|
artikel
|
| 96 |
117P Molecular and pathological characterization of early gastric cancer in Mongolia
|
Bold-Erdene, A.
|
|
|
33 |
S8 |
p. S1419
|
artikel
|
| 97 |
63P Molecular markers as predictors of response to perioperative FLOT chemotherapy in gastric cancer
|
Oganyan, K.
|
|
|
33 |
S8 |
p. S1402
|
artikel
|
| 98 |
129P Molecular screening and early phase trial inclusion for head and neck squamous cell carcinoma patients
|
Vozy, A.
|
|
|
33 |
S8 |
p. S1423-S1424
|
artikel
|
| 99 |
69P Novel urinary methylated DNA biomarkers for kidney cancer detection and prognosis
|
Kubiliute, R.
|
|
|
33 |
S8 |
p. S1404
|
artikel
|
| 100 |
82P Obtaining microvesicles from T-lymphocytes using various methods of induction
|
Zmievskaya, E.
|
|
|
33 |
S8 |
p. S1408
|
artikel
|
| 101 |
95P Organoid sensitivity for panitumumab based on primary tumor location and mutational status
|
Smabers, L.P.
|
|
|
33 |
S8 |
p. S1412
|
artikel
|
| 102 |
136P Paths of chromosomal instability and copy number alteration in circulating tumor cells of progressing early-stage breast cancer patients
|
Silvestri, M.
|
|
|
33 |
S8 |
p. S1426
|
artikel
|
| 103 |
101P Potential immune-oncological effect of liposomal-doxorubicin in breast cancer via tumor microenvironment alteration
|
Sathishkumar, P.
|
|
|
33 |
S8 |
p. S1414
|
artikel
|
| 104 |
128P Precision genomics based targeted 12 gene biomarker and PD-L1 testing in advanced non-small cell lung cancer patients as an alternative to conventional EGFR, ALK, ROS-1 sequential testing in a tertiary care hospital
|
Nagaraj, M.
|
|
|
33 |
S8 |
p. S1423
|
artikel
|
| 105 |
59P Prognostic impact of HPV status evaluation in head and neck squamous cell carcinomas
|
Banias, L.
|
|
|
33 |
S8 |
p. S1401
|
artikel
|
| 106 |
57P Prognostic relationship between EGFR overexpression and enrichment of CD8+ T cell within tumour microenvironment in patients with head and neck squamous cell carcinoma
|
Erdene-Ochir, B.
|
|
|
33 |
S8 |
p. S1401
|
artikel
|
| 107 |
44P Prognostic value of androgen receptor expression in premenopausal women with estrogen receptor-positive breast cancer
|
Yildirim, H.C.
|
|
|
33 |
S8 |
p. S1397
|
artikel
|
| 108 |
47P Prognostic value of dynamic HER2 status conversion in patients with metastatic breast cancer: Retrospective study of the Clinic of Medical Oncology of Military Medical Academy, Sofia, Bulgaria
|
Garev, A.L.
|
|
|
33 |
S8 |
p. S1398
|
artikel
|
| 109 |
32P Prosaposin A as a potential biomarker in patients of squamous cell carcinoma of head and neck
|
Datta, A.
|
|
|
33 |
S8 |
p. S1393
|
artikel
|
| 110 |
105P RADseq for tumour mutation burden estimation and mutation signature analysis
|
McGuinness, C.F.
|
|
|
33 |
S8 |
p. S1415
|
artikel
|
| 111 |
127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma
|
Marinelli, D.
|
|
|
33 |
S8 |
p. S1423
|
artikel
|
| 112 |
102P Regulation of the occurrence of mammary tumors in mice C3H/Sn by action steroid in early postpartum
|
Burlaka, D.
|
|
|
33 |
S8 |
p. S1414
|
artikel
|
| 113 |
33P Reporting recommendations for translational cancer genomic studies: Modified-REMARK checklist
|
Casolino, R.
|
|
|
33 |
S8 |
p. S1394
|
artikel
|
| 114 |
140P Retrospective review of actionable IDH mutations and MGMT promoter methylation among CNS tumors
|
Ahmed, Z.A.
|
|
|
33 |
S8 |
p. S1427
|
artikel
|
| 115 |
29P Sarcoma patients need precision oncology: Is molecular tumor board the right way?
|
Cosimati, A.
|
|
|
33 |
S8 |
p. S1392-S1393
|
artikel
|
| 116 |
92P Selective elimination of CD133+ cancer stem cells using novel BET/HDAC inhibitor TW09 as therapy for pancreatic ductal adenocarcinoma (PDAC)
|
Tiwary, K.
|
|
|
33 |
S8 |
p. S1411
|
artikel
|
| 117 |
26P Serological evaluation of mucins in ovarian cancer
|
Singh, A.R.
|
|
|
33 |
S8 |
p. S1391-S1392
|
artikel
|
| 118 |
125P Serum CXCL8 forms a pro-tumor phenotype of circulating neutrophils in clear cell kidney cancer
|
Abakumova, T.
|
|
|
33 |
S8 |
p. S1422
|
artikel
|
| 119 |
28P SHH pathway-targeted therapy in a relapsed medulloblastoma
|
Alcaide-Alvarez, C.
|
|
|
33 |
S8 |
p. S1392
|
artikel
|
| 120 |
38P Single molecule localization microscopy for extracellular vesicles detection in cancer
|
Pagliuca, M.
|
|
|
33 |
S8 |
p. S1395-S1396
|
artikel
|
| 121 |
78P Small molecule compounds targeting the p53 mutants
|
Khadiullina, R.
|
|
|
33 |
S8 |
p. S1407
|
artikel
|
| 122 |
9P Small-scale ROS1 aberrations: Functional impact and therapeutic potential
|
Glaser, M.
|
|
|
33 |
S8 |
p. S1386
|
artikel
|
| 123 |
113P Spatial transcriptomic profiling of real-world, archival, resected pancreatic ductal adenocarcinomas
|
Cameron, A.J.
|
|
|
33 |
S8 |
p. S1418
|
artikel
|
| 124 |
100P Study on the effect of ursolic acid on MMPs and antimetastatic activity in TNBC cells
|
Rajoriya, S.
|
|
|
33 |
S8 |
p. S1414
|
artikel
|
| 125 |
62P Study on the role and mechanism of HAX-1 and S100A12 in promoting malignant progression of glioma
|
Lu, C.
|
|
|
33 |
S8 |
p. S1402
|
artikel
|
| 126 |
77P Targeted compounds for modulation of mutant p53 activity
|
Khusainova, E.
|
|
|
33 |
S8 |
p. S1407
|
artikel
|
| 127 |
86P Targeting signaling pathways by natural products in glioblastoma
|
Tanase, C.
|
|
|
33 |
S8 |
p. S1409-S1410
|
artikel
|
| 128 |
120P The compartment-specific spatial transcriptomic landscape of 3D cultured Gleason 7 prostate cancer
|
Thavarajah, V.
|
|
|
33 |
S8 |
p. S1420
|
artikel
|
| 129 |
40P The detection and quantification of different sequence-variable NPM1 mutations using RNase H-dependent PCR (rhPCR)
|
Gaina, G.
|
|
|
33 |
S8 |
p. S1396
|
artikel
|
| 130 |
103P The effect of carboplatin on sodium-dependent phosphate transporter NaPi2b expression in the OVCAR-4 ovarian cancer cell line
|
Nurgalieva, A.K.
|
|
|
33 |
S8 |
p. S1414-S1415
|
artikel
|
| 131 |
88P The effect of flubendazole on microtubule polymerization and post-translational modifications
|
Vitovcova, B.
|
|
|
33 |
S8 |
p. S1410
|
artikel
|
| 132 |
89P The effect of flubendazole on temozolomide treatment in glioblastoma cell
|
Dvorakova, K.
|
|
|
33 |
S8 |
p. S1410-S1411
|
artikel
|
| 133 |
83P The efficacy of combining adoptive immunotherapy by human Vγ2Vδ2 T cells and PD-1 checkpoint blockade against human prostate cancer
|
Nada, M.H.
|
|
|
33 |
S8 |
p. S1409
|
artikel
|
| 134 |
12P The efficacy of EGFR tyrosine kinase inhibitors and its clinical prognostic factors in lung adenocarcinoma patients harboring different types of EGFR mutations: Real-world data
|
Vitorino, M.
|
|
|
33 |
S8 |
p. S1387-S1388
|
artikel
|
| 135 |
46P The impact of antibiotics and proton pump inhibitors in neoadjuvant treatment of HER2+ breast cancer
|
Martins, J.B.
|
|
|
33 |
S8 |
p. S1397-S1398
|
artikel
|
| 136 |
56P The prognostic role of KRAS mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy
|
Gallina, F.T.
|
|
|
33 |
S8 |
p. S1400-S1401
|
artikel
|
| 137 |
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
|
Tiberio, P.
|
|
|
33 |
S8 |
p. S1398
|
artikel
|
| 138 |
53P The role of p53 gene suppressor and bcl-2 oncoprotein in germ cell ovarian tumor prognosis determination among child and adolescent patients
|
Shukullaev, A.T.
|
|
|
33 |
S8 |
p. S1399-S1400
|
artikel
|
| 139 |
99P The transcriptional atlas of co-targeted PIM/PI3K/mTOR ex-vivo patient-derived prostate cancer as revealed by spatial transcriptomics
|
Okoli, U.A.
|
|
|
33 |
S8 |
p. S1413-S1414
|
artikel
|
| 140 |
50P Transcriptomic profiles of CD32b in breast cancer predict outcome and are associated with immune activation
|
Rojas Laimito, K.I.
|
|
|
33 |
S8 |
p. S1398-S1399
|
artikel
|
| 141 |
122P Transforming growth factor beta type II receptor (TβR2) expression associations with N-cadherin (N-cad) expression in prostate cancer (PCa)
|
Puchinskaya, M.
|
|
|
33 |
S8 |
p. S1421
|
artikel
|
| 142 |
18P Trastuzumab in HER2-amplified or overexpressed gallbladder cancer: Experience from an Indian cancer center
|
Mondal, D.
|
|
|
33 |
S8 |
p. S1389
|
artikel
|
| 143 |
106P Ultra low-coverage whole genome sequencing for precision oncology in solid tumors
|
Tarawneh, T.S.
|
|
|
33 |
S8 |
p. S1415-S1416
|
artikel
|
| 144 |
107P Ultra-sensitive monitoring mutations in cancer patients using superRCA mutation detection assays
|
Chen, L.
|
|
|
33 |
S8 |
p. S1416
|
artikel
|
| 145 |
91P Understanding the basis for acquired resistance to KRASG12C inhibitors
|
Santos Ramos, A.
|
|
|
33 |
S8 |
p. S1411
|
artikel
|
| 146 |
14P Up-regulated PI3K/mTOR/AKT pathway behind the downregulation of PTEN, FBXW7, genes and miRNA 140-145, ALK mediated chemotherapy resistance in non-small cell lung carcinoma (NSCLC)
|
Aslam, M.J.
|
|
|
33 |
S8 |
p. S1388
|
artikel
|
| 147 |
68P Urinary biomarkers for prognosis of histologically confirmed small renal tumors
|
Zalimas, A.
|
|
|
33 |
S8 |
p. S1404
|
artikel
|
| 148 |
71P Usefulness of circulating mitochondrial DNA copy number as a prognostic biomarker in metastatic patients
|
Moreau, M.
|
|
|
33 |
S8 |
p. S1405
|
artikel
|
| 149 |
23P Vitamin D deficiency and SNPs in melatonin pathway genes potentiate breast cancer susceptibility: A pilot study
|
Jayaraman, S.
|
|
|
33 |
S8 |
p. S1390-S1391
|
artikel
|
| 150 |
134P Whole transcriptome RNA-Seq analysis of formalin-fixed and paraffin-embedded tumour tissue
|
Hajkova, N.
|
|
|
33 |
S8 |
p. S1425
|
artikel
|
| 151 |
Table of Contents
|
|
|
|
33 |
S8 |
p. iv
|
artikel
|
| 152 |
148TiP Adipokine hormonal receptor expression within the breast cancer microenvironment and their role in patient prognosis
|
Tchabashvili, L.
|
|
|
33 |
S8 |
p. S1430
|
artikel
|
| 153 |
147TiP Exactis-01 - Clinical utility of returning liquid biopsy NGS results in NSCL cancer patients: A Canadian trial through the Exactis Network
|
Marques, M.
|
|
|
33 |
S8 |
p. S1429-S1430
|
artikel
|
| 154 |
Title page and disclaimer
|
|
|
|
33 |
S8 |
p. iii
|
artikel
|
| 155 |
UNICANCER
|
|
|
|
33 |
S8 |
p. vii
|
artikel
|
Tijdschrift beschrijving